OPCH Stock Overview
Option Care Health, Inc. offers home and alternate site infusion services in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Option Care Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$30.59 |
| 52 Week High | US$35.74 |
| 52 Week Low | US$24.23 |
| Beta | 1.3 |
| 1 Month Change | -6.54% |
| 3 Month Change | -2.36% |
| 1 Year Change | -3.23% |
| 3 Year Change | 59.24% |
| 5 Year Change | n/a |
| Change since IPO | 176.08% |
Recent News & Updates
Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Apr 11
Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 42% Discount?
Mar 28Recent updates
Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Apr 11Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 42% Discount?
Mar 28Is It Time To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Feb 12Option Care Health (NASDAQ:OPCH) Has A Pretty Healthy Balance Sheet
Jan 02There's Reason For Concern Over Option Care Health, Inc.'s (NASDAQ:OPCH) Price
Dec 19Is There An Opportunity With Option Care Health, Inc.'s (NASDAQ:OPCH) 27% Undervaluation?
Dec 06With EPS Growth And More, Option Care Health (NASDAQ:OPCH) Makes An Interesting Case
Nov 08Is It Too Late To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Oct 26Does Option Care Health (NASDAQ:OPCH) Have A Healthy Balance Sheet?
Sep 13Is Option Care Health, Inc. (NASDAQ:OPCH) Trading At A 24% Discount?
Aug 30Does Option Care Health (NASDAQ:OPCH) Deserve A Spot On Your Watchlist?
Aug 10Is Option Care Health, Inc. (NASDAQ:OPCH) Potentially Undervalued?
Jul 27Here's Why Option Care Health (NASDAQ:OPCH) Can Manage Its Debt Responsibly
Jun 09An Intrinsic Calculation For Option Care Health, Inc. (NASDAQ:OPCH) Suggests It's 37% Undervalued
May 25What Is Option Care Health, Inc.'s (NASDAQ:OPCH) Share Price Doing?
Apr 24Here's Why We Think Option Care Health (NASDAQ:OPCH) Might Deserve Your Attention Today
Apr 11We Like These Underlying Return On Capital Trends At Option Care Health (NASDAQ:OPCH)
Mar 17Option Care Health (NASDAQ:OPCH) Seems To Use Debt Quite Sensibly
Mar 05Estimating The Intrinsic Value Of Option Care Health, Inc. (NASDAQ:OPCH)
Feb 21Should You Think About Buying Option Care Health, Inc. (NASDAQ:OPCH) Now?
Jan 16Should You Be Adding Option Care Health (NASDAQ:OPCH) To Your Watchlist Today?
Jan 04Some Shareholders Feeling Restless Over Option Care Health, Inc.'s (NASDAQ:OPCH) P/E Ratio
Dec 05We Think Option Care Health (NASDAQ:OPCH) Can Stay On Top Of Its Debt
Nov 22The Return Trends At Option Care Health (NASDAQ:OPCH) Look Promising
Nov 10Option Care Health, Inc.'s (NASDAQ:OPCH) Intrinsic Value Is Potentially 41% Above Its Share Price
Sep 30Is Now The Time To Put Option Care Health (NASDAQ:OPCH) On Your Watchlist?
Sep 12Option Care Health announces secondary offering of 11M shares of common stock
Aug 16Option Care Health: Trigger Heavy On This Long-Term Cash Compounder
Aug 10At US$34.49, Is Option Care Health, Inc. (NASDAQ:OPCH) Worth Looking At Closely?
Aug 07Option Care Health Q2 2022 Earnings Preview
Jul 26Are Investors Undervaluing Option Care Health, Inc. (NASDAQ:OPCH) By 35%?
Jun 30We Think Option Care Health (NASDAQ:OPCH) Can Stay On Top Of Its Debt
Jun 18Is Now The Time To Put Option Care Health (NASDAQ:OPCH) On Your Watchlist?
Jun 06Option Care Health (NASDAQ:OPCH) Is Doing The Right Things To Multiply Its Share Price
May 25Option Care Health: Top Infusion Therapy Player With Promising Growth Prospects
May 04Is It Time To Consider Buying Option Care Health, Inc. (NASDAQ:OPCH)?
Apr 29Shareholder Returns
| OPCH | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 1.1% | 2.1% | 1.2% |
| 1Y | -3.2% | 3.6% | 24.7% |
Return vs Industry: OPCH underperformed the US Healthcare industry which returned 4% over the past year.
Return vs Market: OPCH underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| OPCH volatility | |
|---|---|
| OPCH Average Weekly Movement | 4.0% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: OPCH has not had significant price volatility in the past 3 months.
Volatility Over Time: OPCH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 6,806 | John Rademacher | www.optioncarehealth.com |
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.
Option Care Health, Inc. Fundamentals Summary
| OPCH fundamental statistics | |
|---|---|
| Market cap | US$5.32b |
| Earnings (TTM) | US$272.67m |
| Revenue (TTM) | US$4.43b |
19.5x
P/E Ratio1.2x
P/S RatioIs OPCH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OPCH income statement (TTM) | |
|---|---|
| Revenue | US$4.43b |
| Cost of Revenue | US$3.44b |
| Gross Profit | US$990.72m |
| Other Expenses | US$718.05m |
| Earnings | US$272.67m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.57 |
| Gross Margin | 22.35% |
| Net Profit Margin | 6.15% |
| Debt/Equity Ratio | 73.9% |
How did OPCH perform over the long term?
See historical performance and comparison